当前位置: 首页 > 期刊 > 《中外女性健康研究》 > 20204
编号:13505687
硫酸镁联合硝苯地平联合治疗对妊高症患者血清hs-CRP、sVCAM-1水平的影响(1)
http://www.100md.com 2020年2月15日 《中外女性健康研究》 20204
     【摘 要】目的:研究硫酸镁联合硝苯地平治疗妊高症疗效。方法:选本院妊高症患者140例,随机均分成两组。对照组:单纯采用硫酸镁治疗;研究组:采用硫酸镁和硝苯地平联合治疗。比较两组患者治疗结局。结果:两组患者hs-CRP、sVCAM-1的水平均有一定程度的改善,但研究组改善程度优于对照组;两组患者血压水平均有不同程度的改善,但研究组患者DBPV、SBPV的水平改善更明显差异显著,P<0.05。结论:硫酸镁以及硝苯地平联合应用治疗妊高症能够显著降低患hs-CRP、sVCAM-1的水平,降低患者的血压,对妊高症的治疗与控制有显著的积极意义,是一种优秀的临床用药治疗方案。

    【关键词】硝苯地平;硫酸镁;妊高症;C反应蛋白

    [Abstract] Objective:To study the efficacy of magnesium sulfate combined with nifedipine in the treatment of pregnancy induced hypertension. Methods: A total of 140 patients with pregnancy-induced hypertension were randomly divided into two groups. Control group: treatment with magnesium sulfate alone; experimental group: combined treatment with magnesium sulfate and nifedipine. The treatment outcomes of the two groups were compared. Results: The levels of hs-CRP and sVCAM-1 in the two groups were improved to some extent ......
1 2下一页

您现在查看是摘要页,全文长 3431 字符